Experimental production of microangiopathic haemolytic anaemia in vivo.
D000614:Aminocaproates / Q000494:pharmacology; D000743:Anemia, Hemolytic / Q000209:etiology*; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D001792:Blood Platelets / Q000528:radiation effects; D004913:Erythrocytes, Abnormal; D005337:Fibrin; D005342:Fibrinolysis / Q000187:drug effects; D006454:Hemoglobins; D006493:Heparin / Q000494:pharmacology; D011817:Rabbits; D013025:Glycine max; D013927:Thrombosis / Q000209:etiology*; D014361:Trypsin Inhibitors / Q000494:pharmacology; D014688:Venoms / Q000494:pharmacology; D014859:Warfarin / Q000494:pharmacology
D000614:Aminocaproates; D006454:Hemoglobins; D014361:Trypsin Inhibitors; D014688:Venoms; D014859:Warfarin; D005337:Fibrin; D006493:Heparin